Table S1. Demographic and clinical features of human subjects used in this study. Figure S1. Aβ deposition in microvessels in AD patients and APPSw/0 mice. Figure S2. Biochemical analysis of Aβ42 aggregates. Figure S3. Cy3-Aβ42 cellular uptake in wild type mouse brain slices within 30 min. Figure S4. Pericyte coverages in Lrp1lox/lox and Lrp1lox/lox; Cspg4-Cre mice. Figure S5.. LRP1 and apoE suppression with siRNA. (DOCX 1454 kb
Table S1. Demographic and pathological data on brain samples. Figure S1. Characterization of AD brai...
Characterization of Plcg2 cell-type co-expression. A) Multiplex RNAScope for Plcg2 and Glast followe...
Figure S3. HFD affects clearance of ISF Aβ. a, b The expression of APP, CTFα/β, BACE1 ADAM10 and α–t...
Aβ plaque onset age in 5XFAD/apoEm/m and 5XFAD/apoE4/4 brain. Aβ immunostaining was performed using ...
The ratio of mouse apoE to human apoE4 within different amyloid lesions in 10 month old 5XFAD/apoEm/...
Specific antibodies for mouse apoE and human apoE4 immunostaining. 5XFAD/apoEm/m and 5XFAD/apoE4/4 b...
BACKGROUND: Clearance at the blood-brain barrier (BBB) plays an important role in removal of Alzheim...
Plcg2 in situ hybridization on brain tissue. A) RNAScope for PLCG2, positive (PPIB) and negative (Da...
Radial distribution around arteries is greater for non-lipidated than lapidated apoE4. A-H) Represen...
Figure S2. (A) Quantification of amyloid plaque load (% of total ROI area) in male (M) and female (F...
Figure S1. Analysis of APP levels in uninoculated AppNL-F mice. a Immunoblots of brain homogenates f...
AQP4 deficiency did not affect LRP1 expression by neurons in APP/PS1 mice. (A) LRP1 immunohistochemi...
Specific ELISA for mouse apoE and human apoE. a Mouse apoE was detected by using HJ6.2 as the captur...
Regional analysis of perivascular hemosiderin deposits identifies the brain cortex in mice of all AP...
Figure S1. Effect of rHDL-rApoJ or free rApoJ treatment in the levels of mouse ApoJ in brain homogen...
Table S1. Demographic and pathological data on brain samples. Figure S1. Characterization of AD brai...
Characterization of Plcg2 cell-type co-expression. A) Multiplex RNAScope for Plcg2 and Glast followe...
Figure S3. HFD affects clearance of ISF Aβ. a, b The expression of APP, CTFα/β, BACE1 ADAM10 and α–t...
Aβ plaque onset age in 5XFAD/apoEm/m and 5XFAD/apoE4/4 brain. Aβ immunostaining was performed using ...
The ratio of mouse apoE to human apoE4 within different amyloid lesions in 10 month old 5XFAD/apoEm/...
Specific antibodies for mouse apoE and human apoE4 immunostaining. 5XFAD/apoEm/m and 5XFAD/apoE4/4 b...
BACKGROUND: Clearance at the blood-brain barrier (BBB) plays an important role in removal of Alzheim...
Plcg2 in situ hybridization on brain tissue. A) RNAScope for PLCG2, positive (PPIB) and negative (Da...
Radial distribution around arteries is greater for non-lipidated than lapidated apoE4. A-H) Represen...
Figure S2. (A) Quantification of amyloid plaque load (% of total ROI area) in male (M) and female (F...
Figure S1. Analysis of APP levels in uninoculated AppNL-F mice. a Immunoblots of brain homogenates f...
AQP4 deficiency did not affect LRP1 expression by neurons in APP/PS1 mice. (A) LRP1 immunohistochemi...
Specific ELISA for mouse apoE and human apoE. a Mouse apoE was detected by using HJ6.2 as the captur...
Regional analysis of perivascular hemosiderin deposits identifies the brain cortex in mice of all AP...
Figure S1. Effect of rHDL-rApoJ or free rApoJ treatment in the levels of mouse ApoJ in brain homogen...
Table S1. Demographic and pathological data on brain samples. Figure S1. Characterization of AD brai...
Characterization of Plcg2 cell-type co-expression. A) Multiplex RNAScope for Plcg2 and Glast followe...
Figure S3. HFD affects clearance of ISF Aβ. a, b The expression of APP, CTFα/β, BACE1 ADAM10 and α–t...